Elevance Health, Inc. (ELV) Fair Value 2026

ELV · Healthcare Plans ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.4 /10

32 fundamental signals · 6 models active

Value Trap Risk

SAFE (8/100)

Quick Summary — As of 2026-08-27, Elevance Health, Inc. (ELV) trades at $399.11, versus a $356.10 median fair value across its 6 active models — 10.8% below the current price. QOC: 8.4/10. Value Trap Risk: 8/100 (SAFE). 6/13 models active.

Key Facts

Ticker
ELV
Price
$399.11
Quality Score
8.4/10
Value Trap Risk
8/100
Models Active
6/13
Last Updated
Strength: Quality Score of 8.4/10 indicates strong fundamentals
Risk: Majority of models suggest overvaluation

Is Elevance Health, Inc. (ELV) Undervalued or Overvalued in 2026?

According to CirclFi’s 6-model valuation engine, Elevance Health, Inc. (ELV) appears overvalued as of : the median of 6 independent fair value estimates is $356.10, 10.8% below the current price of $399.11. Estimates range from $280.49 to $935.43. ELV scores 8.4/10 on fundamental quality and 8/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. ELV’s -10.8% gap is narrower than that market norm. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Elevance Health, Inc. Stock in 2026? →

What Fair Value Does Each Model Give ELV?

6 Intrinsic Value Models vs. Current Price ($399.11)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $316.27 -20.8%
Ensemble · Medium Conviction
 $372.38 -6.7%
Intrinsic · High Conviction
 $339.81 -14.9%
Unlock the Full Matrix

Access 3 additional models including ML-RIV, Regime Cross-Sectional, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 6 Models →

Cancel anytime · No contracts · Instant access

What Is ELV's Fair Value Range?

Spread across 6 independent models · $280.49 to $935.43

CirclFi's 6 active models place Elevance Health, Inc. (ELV) between $280.49 and $935.43 per share, a spread of 184% of the median. The median of that range — $356.10 — is the fair value CirclFi publishes for ELV, against a current price of $399.11.

Low · ML-RIVHigh · Regime Cross
$280.49median $356.10$935.43
Where the range comes from
Most bearish modelML Residual Income$280.49
Most bullish modelRegime Cross-Sectional$935.43
Model agreement2 bullish · 4 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for ELV. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on ELV, not a CirclFi price target. How each model works →

What Is Elevance Health, Inc. (ELV) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the balance of valuation evidence tilts cautious on Elevance Health, Inc. at its current price of $399.11. The median intrinsic value is estimated at $356.10 (-10.8% vs price), with 4 models flagging overvaluation risk. The most optimistic model, Regime Cross, places fair value at $935.43 (+134.4%), while ML-RIV — the most conservative — estimates $280.49 (-29.7%). This +164.1% gap reflects genuine analytical uncertainty about Elevance Health, Inc.'s intrinsic worth. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About ELV?

6 of 13 models are currently active for ELV. Of these, 2 models suggest upside while 4 models suggest overvaluation. Taken together, their median fair value for ELV is $356.10 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does ELV Rank in Healthcare Plans?

Among 12 Healthcare Plans stocks, ELV ranks #3 by Quality of Company score. CirclFi's QOC score of 8.4/10 evaluates 32 fundamental signals. A score of 8.4 places ELV in the top tier.

Within the Healthcare Plans space, Elevance Health, Inc. competes in an environment where FDA approval probability often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ELV a Value Trap?

CirclFi's Value Trap algorithm assigns ELV a score of 8/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

6 of 13 models are active for Elevance Health, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Elevance Health, Inc.'s fundamental quality profile registers 8.4/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

The gap between the most bullish and bearish model spans +164.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ELV valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ELV's 6 active models, average confidence is 48%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Elevance Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Healthcare Plans Stocks Should You Also Analyze?

11 related Healthcare Plans stocks with 13-model coverage

PGNYProgyny, Inc.QOC 8.6PFHOPacific Health Care Organization, Inc.QOC 8.5UNHUnitedHealth Group IncorporatedQOC 8.0CIThe Cigna GroupQOC 7.9MOHMolina Healthcare, Inc.QOC 7.7HUMHumana Inc.QOC 7.6CNCCentene CorporationQOC 7.4ALHCAlignment Healthcare, Inc.QOC 7.2OSCROscar Health, Inc.QOC 7.1CLOVClover Health Investments, Corp.QOC 6.5MRAIMarpai, Inc.QOC 4.2

Read investment analysis: PGNY · PFHO · UNH · CI · MOH · HUM · CNC · ALHC · OSCR · CLOV · MRAI

Which Other Stocks Have a Similar Quality Score to ELV?

7 companies across all industries closest to ELV’s Quality of Company score of 8.4/10.

FHBFirst Hawaiian, Inc.QOC 8.4HAFCHanmi Financial CorporationQOC 8.4WBWeibo CorporationQOC 8.4EQBKEquity Bancshares, Inc.QOC 8.4STRTStrattec Security CorporationQOC 8.4FRSTPrimis Financial Corp.QOC 8.4NVDANVIDIA CorporationQOC 10.0

Read investment analysis: FHB · HAFC · WB · EQBK · STRT · FRST · NVDA

What Else Do Investors Ask About Elevance Health, Inc.’s Valuation?

What is Elevance Health, Inc.'s intrinsic value in 2026?

CirclFi puts Elevance Health, Inc. (ELV)'s intrinsic value at $356.10 — the median of 6 independent model estimates as of 2026-08-27, ranging from $280.49 to $935.43. The Quality of Company score is 8.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ELV overvalued or undervalued right now?

At $399.11, 2 of 6 active models suggest ELV may be undervalued, while 4 indicate potential overvaluation. The median of all 6 fair value estimates is $356.10, 10.8% below the current price of $399.11 — a consensus view that ELV is overvalued. The assessment depends on which methodology best fits Elevance Health, Inc.'s business model in Healthcare Plans.

What does a Quality of Company score of 8.4 mean for ELV?

Elevance Health, Inc.'s QOC of 8.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on ELV?

CirclFi analyzes ELV with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 6 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on ELV?

Of the 6 models currently active on ELV, Regime Cross-Sectional is the most bullish at $935.43 per share, and ML Residual Income is the most bearish at $280.49. CirclFi's published fair value for ELV is the median of that range, $356.10, not either extreme. The gap between the two ends equals 184% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is ELV a value trap in 2026?

Elevance Health, Inc.'s Value Trap score is 8/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 6-model valuation engine, Elevance Health, Inc. (ELV) has a median fair value of $356.10 — 10.8% below the current price of $399.11 — as of 2026-08-27.” Source: circlfi.com/stock/ELV/ · Methodology
Primary sources for this ELV valuation
  • Financial statements: Elevance Health, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001156039) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ELV as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 6 mathematical frameworks give you clarity on ELV.

Unlock All 6 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

3 models hidden for ELV Unlock All 6 — $39/mo